From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

Like this article?

Get your free daily medical news from Physician's First Watch.

RSS

Pioglitazone Linked with Increased Fracture Risk in Women

The FDA warned physicians of an increased fracture risk in women taking medications containing pioglitazone for type 2 diabetes.

In a letter to healthcare providers, Takeda Pharmaceuticals reports that an analysis of their clinical trials database found that patients on pioglitazone had a fracture incidence of 1.9 fractures per 100 patient-years, compared with an incidence of 1.1 for those on placebo or a different drug. There was no increased risk in men. Most fractures occurred in the patients' distal limbs.

The FDA advised clinicians to consider fracture risk when treating women with pioglitazone. The warning applies to Actos (pioglitazone), Actoplus met (pioglitazone and metformin), and Duetact (pioglitazone and glimepiride).

Last month, the agency issued a similar warning on rosiglitazone.

Link: FDA notice on pioglitazone (Free)

Link: Manufacturer's letter (Free PDF)

Link: Physician's First Watch coverage of rosiglitazone warning. (Free)

Published in Physician's First Watch March 12, 2007

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2007. Massachusetts Medical Society. All rights reserved.